Melatonin-mediated corrective changes in gut microbiota of experimentally chronodisrupted C57BL/6J mice

References

• Ali EM, Madkour HI. 2023. Effect of melatonin on experimentally induced acute pancreatitis and associated hyperlipidemia. Rec Pharm Biomedical Sci. 7:91–102. doi: 10.21608/rpbs.2023.206081.1224.
   Google Scholar
• Anderson G, Maes M. 2020. Gut dysbiosis dysregulates central and systemic homeostasis via suboptimal mitochondrial function: assessment, treatment and classification implications. CTMC. 20:524–539. doi: 10.2174/1568026620666200131094445.
   Google Scholar
• Antunes LDC, Levandovski R, Dantas G, Caumo W, Hidalgo MP. 2010. Obesity and shift work: Chronobiological aspects. Nutr Res Rev. 23:155–168. doi: 10.1017/S0954422410000016.
   PubMed Web of Science ®Google Scholar
• Bahar-Tokman H, Demirci M, Keskin FE, Cagatay P, Taner Z, Ozturk-Bakar Y, Ozyazar M, Kiraz N, Kocazeybek BS. 2022. Firmicutes/Bacteroidetes ratio in the gut microbiota and IL-1β, IL-6, IL-8, TLR2, TLR4, TLR5 gene expressions in type 2 diabetes. Clin Lab. 68. doi: 10.7754/Clin.Lab.2022.211244.
   PubMed Web of Science ®Google Scholar
• Baumann A, Jin C, Brandt A, Sellmann C, Nier A, Burkard M, Venturelli S, Bergheim I. 2020. Oral supplementation of sodium butyrate attenuates the progression of non-alcoholic steatohepatitis. Nutrients. 12:951. doi: 10.3390/nu12040951.
   PubMed Web of Science ®Google Scholar
• Bedrosian TA, Fonken LK, Nelson RJ. 2016. Endocrine effects of circadian disruption. Annu Rev Physiol. 78:109–131. doi: 10.1146/annurev-physiol-021115-105102.
   PubMed Web of Science ®Google Scholar
• Camilleri M. 2019. Leaky gut: Mechanisms, measurement and clinical implications in humans. Gut. 68:1516–1526. doi: 10.1136/gutjnl-2019-318427.
   PubMed Web of Science ®Google Scholar
• Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R. 2008. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet–induced obesity and diabetes in mice. Diabetes. 57:1470–1481. doi: 10.2337/db07-1403.
   PubMed Web of Science ®Google Scholar
• Chan YK, Brar MS, Kirjavainen PV, Chen Y, Peng J, Li D, Leung F-C-C, El-Nezami H. 2016. High fat diet induced atherosclerosis is accompanied with low colonic bacterial diversity and altered abundances that correlates with plaque size, plasma A-FABP and cholesterol: A pilot study of high fat diet and its intervention with lactobacillus rhamnosus GG (LGG) or telmisartan in ApoE−/− mice. BMC Microbiol. 16:1–13. doi: 10.1186/s12866-015-0617-z.
   PubMed Web of Science ®Google Scholar
• Chudzicka-Strugała I, Kubiak A, Banaszewska B, Zwozdziak B, Siakowska M, Pawelczyk L, Duleba AJ. 2021. Effects of synbiotic supplementation and lifestyle modifications on women with polycystic ovary syndrome. J Clin Endocr Metab. 106:2566–2573. doi: 10.1210/clinem/dgab369.
   PubMed Web of Science ®Google Scholar
• Cox KH, Takahashi JS. 2019. Circadian clock genes and the transcriptional architecture of the clock mechanism. J Mol Endocrinol. 63:R93–R102. doi: 10.1530/JME-19-0153.
   PubMed Web of Science ®Google Scholar
• de La Serre CB, Ellis CL, Lee J, Hartman AL, Rutledge JC, Raybould HE. 2010. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol-Gastr L. 299:G440–G448. doi: 10.1152/ajpgi.00098.2010.
   PubMed Web of Science ®Google Scholar
• Deschasaux M, Bouter KE, Prodan A, Levin E, Groen AK, Herrema H, Tremaroli V, Bakker GJ, Attaye I, Pinto-Sietsma S-J. 2018. Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography. Nat Med. 24:1526–1531. doi: 10.1038/s41591-018-0160-1.
   PubMed Web of Science ®Google Scholar
• Dimba NR, Mzimela N, Mosili P, Ngubane PS, Khathi A. 2023. Investigating the association between diet-induced “leaky gut” and the development of prediabetes. Exp Clin Endocrinol Diabetes. 131:569–576. doi: 10.1055/a-2181-6664.
   PubMed Web of Science ®Google Scholar
• Di Palo DM, Garruti G, Di Ciaula A, Molina-Molina E, Shanmugam H, De Angelis M, Portincasa P. 2020. Increased colonic permeability and lifestyles as contributing factors to obesity and liver steatosis. Nutrients. 12:564. doi: 10.3390/nu12020564.
   PubMed Web of Science ®Google Scholar
• Fasano A. 2017. Gut permeability, obesity, and metabolic disorders: Who is the chicken and who is the egg? Am J Clin Nutr. 105:3–4. Oxford University Press. doi:10.3945/ajcn.116.148338.
   PubMed Web of Science ®Google Scholar
• Fasano A. 2020. All disease begins in the (leaky) gut: Role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases. F1000Research. 9:9. doi: 10.12688/f1000research.20510.1.
   PubMedGoogle Scholar
• Gao X, Cao Q, Cheng Y, Zhao D, Wang Z, Yang H, Wu Q, You L, Wang Y, Lin Y. 2018. Chronic stress promotes colitis by disturbing the gut microbiota and triggering immune system response. Proc Natl Acad Sci USA. 115:E2960–E2969. doi: 10.1073/pnas.1720696115.
   PubMed Web of Science ®Google Scholar
• Garaulet M, Qian J, Florez JC, Arendt J, Saxena R, Scheer FAJL. 2020. Melatonin effects on glucose metabolism: Time to unlock the controversy. Trends In Endocrinol Metabolism. 31:192–204. doi: 10.1016/j.tem.2019.11.011.
   PubMed Web of Science ®Google Scholar
• Gasmi A, Mujawdiya PK, Pivina L, Doşa A, Semenova Y, Benahmed AG, Bjørklund G. 2021. Relationship between gut microbiota, gut hyperpermeability and obesity. Curr Med Chem. 28:827–839. doi: 10.2174/0929867327666200721160313.
   PubMed Web of Science ®Google Scholar
• Gomes AC, Hoffmann C, Mota JF. 2018. The human gut microbiota: metabolism and perspective in obesity. Gut Microbes. 9:308–325. doi: 10.1080/19490976.2018.1465157.
   PubMed Web of Science ®Google Scholar
• González-Ramos S, Paz-García M, Fernández-García V, Portune KJ, Acosta-Medina EF, Sanz Y, Castrillo A, Martín-Sanz P, Obregon MJ, Boscá L. 2020. NOD1 deficiency promotes an imbalance of thyroid hormones and microbiota homeostasis in mice fed high fat diet. Sci Rep. 10:12317. doi: 10.1038/s41598-020-69295-2.
   PubMed Web of Science ®Google Scholar
• Hamed SA, Mohan A, Navaneetha Krishnan S, Wang A, Drikic M, Prince NL, Lewis IA, Shearer J, Åv K, Söderholm JD, et al. 2023. Butyrate reduces adherent-invasive E. coli -evoked disruption of epithelial mitochondrial morphology and barrier function: Involvement of free fatty acid receptor 3. Gut Microbes. 15. doi: 10.1080/19490976.2023.2281011.
   PubMed Web of Science ®Google Scholar
• Hong F, Pan S, Xu P, Xue T, Wang J, Guo Y, Jia L, Qiao X, Li L, Zhai Y. 2020. Melatonin orchestrates lipid homeostasis through the hepatointestinal circadian clock and microbiota during constant light exposure. Cells. 9:489. doi: 10.3390/cells9020489.
   PubMed Web of Science ®Google Scholar
• Isojima Y, Okumura N, Nagai K. 2003. Molecular mechanism of mammalian circadian clock. J Biochem. 134:777–784. doi: 10.1093/jb/mvg219.
   PubMed Web of Science ®Google Scholar
• Jasirwan COM, Muradi A, Hasan I, Simadibrata M, Rinaldi I. 2021. Correlation of gut firmicutes/bacteroidetes ratio with fibrosis and steatosis stratified by body mass index in patients with non-alcoholic fatty liver disease. Biosci Microbiota Food Health. 40:50–58. doi: 10.12938/bmfh.2020-046.
   PubMed Web of Science ®Google Scholar
• Ji Y, Yin Y, Li Z, Zhang W. 2019. Gut microbiota-derived components and metabolites in the progression of non-alcoholic fatty liver disease (NAFLD). Nutrients. 11:1712. doi: 10.3390/nu11081712.
   PubMed Web of Science ®Google Scholar
• Joshi A, Upadhyay KK, Vohra A, Shirsath K, Devkar R. 2021. Melatonin induces Nrf2‐HO‐1 reprogramming and corrections in hepatic core clock oscillations in non‐alcoholic fatty liver disease. FASEB J. 35:e21803. doi: 10.1096/fj.202002556RRR.
   PubMed Web of Science ®Google Scholar
• Kettner NM, Voicu H, Finegold MJ, Coarfa C, Sreekumar A, Putluri N, Katchy CA, Lee C, Moore DD, Fu L. 2016. Circadian homeostasis of liver metabolism suppresses hepatocarcinogenesis. Cancer Cell. 30:909–924. doi: 10.1016/j.ccell.2016.10.007.
   PubMed Web of Science ®Google Scholar
• Kim B-R, Shin J, Guevarra RB, Lee JH, Kim DW, Seol K-H, Lee J-H, Kim HB, Isaacson RE. 2017. Deciphering diversity indices for a better understanding of microbial communities. J Microbiol Biotechnol. 27:2089–2093. doi: 10.4014/jmb.1709.09027.
   PubMed Web of Science ®Google Scholar
• Koliada A, Syzenko G, Moseiko V, Budovska L, Puchkov K, Perederiy V, Gavalko Y, Dorofeyev A, Romanenko M, Tkach S. 2017. Association between body mass index and firmicutes/bacteroidetes ratio in an adult Ukrainian population. BMC Microbiol. 17:1–6. doi: 10.1186/s12866-017-1027-1.
   PubMed Web of Science ®Google Scholar
• Lange K, Buerger M, Stallmach A, Bruns T. 2016. Effects of antibiotics on gut microbiota. Dig Dis. 34:260–268. doi: 10.1159/000443360.
   PubMed Web of Science ®Google Scholar
• Leone V, Gibbons SM, Martinez K, Hutchison AL, Huang EY, Cham CM, Pierre JF, Heneghan AF, Nadimpalli A, Hubert N. 2015. Effects of diurnal variation of gut microbes and high-fat feeding on host circadian clock function and metabolism. Cell Host Microbe. 17:681–689. doi: 10.1016/j.chom.2015.03.006.
   PubMed Web of Science ®Google Scholar
• Li Y, Chen Y, Tian X, Zhang S, Jiao J. 2021. Comparison of clinical characteristics between obese and non-obese patients with nonalcoholic fatty liver disease (NAFLD). DMSO. 14:2029–2039. doi: 10.2147/DMSO.S304634.
   Google Scholar
• Li H-Y, Zhou D-D, Gan R-Y, Huang S-Y, Zhao C-N, Shang A, Xu X-Y, Li H-B. 2021. Effects and mechanisms of probiotics, prebiotics, synbiotics, and postbiotics on metabolic diseases targeting gut microbiota: a narrative review. Nutrients. 13:3211. doi: 10.3390/nu13093211.
   PubMed Web of Science ®Google Scholar
• Magne F, Gotteland M, Gauthier L, Zazueta A, Pesoa S, Navarrete P, Balamurugan R. 2020. The firmicutes/bacteroidetes ratio: A relevant marker of gut dysbiosis in obese patients? Nutrients. 12:1474. doi: 10.3390/nu12051474.
   PubMed Web of Science ®Google Scholar
• Maynard C, Weinkove D. 2018. The gut microbiota and ageing. Biochem Cell Biol Age. 351–371.
   Google Scholar
• Muñoz-Jurado A, Escribano BM, Caballero-Villarraso J, Galván A, Agüera E, Santamaría A, Túnez I. 2022. Melatonin and multiple sclerosis: antioxidant, anti-inflammatory and immunomodulator mechanism of action. Inflammopharmacology. 30:1569–1596. doi: 10.1007/s10787-022-01011-0.
   PubMed Web of Science ®Google Scholar
• Nabavi SM, Nabavi SF, Sureda A, Xiao J, Dehpour AR, Shirooie S, Silva AS, Baldi A, Khan H, Daglia M. 2019. Anti-inflammatory effects of melatonin: a mechanistic review. Crit Rev Food Sci Nutr. 59:S4–S16. doi: 10.1080/10408398.2018.1487927.
   PubMed Web of Science ®Google Scholar
• Nejati L, Movahedi A, Salari G, Moeineddin R, Nejati P. 2022. The effect of berberine on lipid profile, liver enzymes, and fasting blood glucose in patients with non-alcoholic Fatty liver disease (NAFLD): a randomized controlled trial. Med. J. Islam. Republ. Iran. doi: 10.47176/mjiri.36.39.
   PubMedGoogle Scholar
• Neto MPC, de Souza Aquino J, Da Silva LDFR, de Oliveira Silva R, de Lima Guimaraes KS, De Oliveira Y, De Souza EL, Magnani M, Vidal H, de Brito Alves JL. 2018. Gut microbiota and probiotics intervention: a potential therapeutic target for management of cardiometabolic disorders and chronic kidney disease? Pharmacol Res. 130:152–163. doi: 10.1016/j.phrs.2018.01.020.
   PubMed Web of Science ®Google Scholar
• Panda S, El Khader I, Casellas F, Lopez Vivancos J, Garcia Cors M, Santiago A, Cuenca S, Guarner F, Manichanh C, Cotter PD. 2014. Short-term effect of antibiotics on human gut microbiota. PloS One. 9:e95476. doi: 10.1371/journal.pone.0095476.
   PubMed Web of Science ®Google Scholar
• Park SH, Kim BI, Kim SH, Kim HJ, Park DI, Cho YK, Sung IK, Sohn CI, Kim H, Keum DK. 2007. Body fat distribution and insulin resistance: beyond obesity in nonalcoholic fatty liver disease among overweight men. J Am Coll Nutr. 26:321–326. doi: 10.1080/07315724.2007.10719618.
   PubMed Web of Science ®Google Scholar
• Paulose JK, Wright JM, Patel AG, Cassone VM, Yamazaki S. 2016. Human gut bacteria are sensitive to melatonin and express endogenous circadian rhythmicity. PloS One. 11:e0146643. doi: 10.1371/journal.pone.0146643.
   PubMed Web of Science ®Google Scholar
• Pevet P, Challet E. 2011. Melatonin: both master clock output and internal time-giver in the circadian clocks network. J Physiol-Paris. 105:170–182. doi: 10.1016/j.jphysparis.2011.07.001.
   PubMed Web of Science ®Google Scholar
• Pilorz V, Helfrich-Förster C, Oster H. 2018. The role of the circadian clock system in physiology. Pflugers Arch Eur J Physiol. 470:227–239. doi: 10.1007/s00424-017-2103-y.
   PubMed Web of Science ®Google Scholar
• Prather H, Cheng J. 2023. Relationship of chronic systemic inflammation to both chronic lifestyle-related diseases and osteoarthritis: the case for lifestyle medicine for osteoarthritis. HSS J. 19:459–466. doi: 10.1177/15563316231193753.
   PubMedGoogle Scholar
• Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, Peplies J, Glöckner FO. 2012. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 41:D590–D596. doi: 10.1093/nar/gks1219.
   PubMed Web of Science ®Google Scholar
• Rohr MW, Narasimhulu CA, Rudeski-Rohr TA, Parthasarathy S. 2020. Negative effects of a high-fat diet on intestinal permeability: a review. Adv Nutr. 11:77–91. doi: 10.1093/advances/nmz061.
   PubMed Web of Science ®Google Scholar
• Scott KP, Gratz SW, Sheridan PO, Flint HJ, Duncan SH. 2013. The influence of diet on the gut microbiota. Pharmacol Res. 69:52–60. doi: 10.1016/j.phrs.2012.10.020.
   PubMed Web of Science ®Google Scholar
• Singh AB, Dong B, Kraemer FB, Xu Y, Zhang Y, Liu J. 2018. Farnesoid X receptor activation by obeticholic acid elevates liver low-density lipoprotein receptor expression by mRNA stabilization and reduces plasma low-density lipoprotein cholesterol in mice. ATVB. 38:2448–2459. doi: 10.1161/ATVBAHA.118.311122.
   Google Scholar
• Stojanov S, Berlec A, Štrukelj B. 2020. The influence of probiotics on the firmicutes/bacteroidetes ratio in the treatment of obesity and inflammatory bowel disease. Microorganisms. 8:1715. doi: 10.3390/microorganisms8111715.
   PubMed Web of Science ®Google Scholar
• Tan J, Hu R, Gong J, Fang C, Li Y, Liu M, He Z, Hou DX, Zhang H, He J, et al. 2023. Protection against metabolic associated fatty liver disease by protocatechuic acid. Gut Microbes. 15. doi: 10.1080/19490976.2023.2238959.
   Web of Science ®Google Scholar
• Turroni F, Ribbera A, Foroni E, van Sinderen D, Ventura M. 2008. Human gut microbiota and bifidobacteria: from composition to functionality. Antonie Van Leeuwenhoek. 94:35–50. doi: 10.1007/s10482-008-9232-4.
   PubMed Web of Science ®Google Scholar
• Vaiserman A, Romanenko M, Piven L, Moseiko V, Lushchak O, Kryzhanovska N, Guryanov V, Koliada A. 2020. Differences in the gut firmicutes to bacteroidetes ratio across age groups in healthy Ukrainian population. BMC Microbiol. 20:1–8. doi: 10.1186/s12866-020-01903-7.
   PubMed Web of Science ®Google Scholar
• Voigt RM, Forsyth CB, Green SJ, Engen PA, Keshavarzian A. 2016. Circadian rhythm and the gut microbiome. Int Rev Neurobiol. 131:193–205.
   PubMed Web of Science ®Google Scholar
• Wang Z, Ye M, Zhang X, Zhang P, Cai J, Li H, She Z. 2022. Impact of NAFLD and its pharmacotherapy on lipid profile and CVD. Atherosclerosis. 355:30–44. doi: 10.1016/j.atherosclerosis.2022.07.010.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zeng M, Wang Z, Qin F, Chen J, He Z. 2021. Dietary polyphenols to combat nonalcoholic fatty liver disease via the gut–brain–liver axis: a review of possible mechanisms. J Agric Food Chem. 69:3585–3600. doi: 10.1021/acs.jafc.1c00751.
   PubMed Web of Science ®Google Scholar
• Wei L, Yue F, Xing L, Wu S, Shi Y, Li J, Xiang X, Lam SM, Shui G, Russell R. 2020. Constant light exposure alters gut microbiota and promotes the progression of steatohepatitis in high fat diet rats. Front Microbiol. 11. doi: 10.3389/fmicb.2020.01975.
   Web of Science ®Google Scholar
• Wright KP Jr, Drake AL, Frey DJ, Fleshner M, Desouza CA, Gronfier C, Czeisler CA. 2015. Influence of sleep deprivation and circadian misalignment on cortisol, inflammatory markers, and cytokine balance. Brain Behav Immun. 47:24–34. doi: 10.1016/j.bbi.2015.01.004.
   PubMed Web of Science ®Google Scholar
• Xu S, Chen L, Hong D, Yang L, Li X, Wang X. 2020. Mean arterial pressure is related to incident nonalcoholic fatty liver disease among the nonobese female with normal low-density lipoprotein cholesterol levels: a large cohort study in China. Gastroenterol Res. Pract. 2020:1–9. doi: 10.1155/2020/3580840.
   Web of Science ®Google Scholar
• Xu P, Wang J, Hong F, Wang S, Jin X, Xue T, Jia L, Zhai Y. 2017. Melatonin prevents obesity through modulation of gut microbiota in mice. J Pineal Res. 62:e12399. doi: 10.1111/jpi.12399.
   Web of Science ®Google Scholar
• Yin J, Li Y, Han H, Chen S, Gao J, Liu G, Wu X, Deng J, Yu Q, Huang X. 2018. Melatonin reprogramming of gut microbiota improves lipid dysmetabolism in high‐fat diet‐fed mice. J Pineal Res. 65:e12524. doi: 10.1111/jpi.12524.
   PubMed Web of Science ®Google Scholar
• Yin J, Li Y, Han H, Ma J, Liu G, Wu X, Huang X, Fang R, Baba K, Bin P, et al. 2020. Administration of exogenous melatonin improves the diurnal rhythms of the gut microbiota in mice fed a high-fat diet. mSystems. 5:10–1128. doi: 10.1128/mSystems.00002-20.
   Web of Science ®Google Scholar
• Yue F, Xing L, Wu S, Wei L, Zhou Z, Shi Y, Lam SM, Shui G, Xiang X, Russell R. 2022. Constant light exposure alters gut microbiota and short‐/medium‐chain fatty acids and aggravates PCOS‐like traits in HFD‐fed rats. Obesity. 30:694–706. doi: 10.1002/oby.23380.
   PubMed Web of Science ®Google Scholar
• Zubidat AE, Haim A. 2017. Artificial light-at-night–a novel lifestyle risk factor for metabolic disorder and cancer morbidity. J Basic Clin Physiol Pharmacol. 28:295–313. doi: 10.1515/jbcpp-2016-0116.
   PubMedGoogle Scholar